Market Insights Consumer OTC Pharmaceuticals

Sleep Aids - Russia

Russia

Revenue in the Sleep Aids market amounts to €97.60m in 2024. The market is expected to grow annually by 3.59% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€1,950m in 2024).
In relation to total population figures, per person revenues of €0.68 are generated in 2024.

Key regions: Philippines, Indonesia, United Kingdom, Canada, Thailand

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Sleep Aids market in Russia has been experiencing steady growth in recent years, driven by changing customer preferences and increasing awareness of sleep disorders.

Customer preferences: Customers in Russia are becoming more aware of the importance of a good night's sleep and the impact it has on their overall health and well-being. As a result, there is a growing demand for sleep aids that can help improve sleep quality and address common sleep disorders such as insomnia. Customers are also looking for natural and non-habit forming sleep aids, as they are more conscious of the potential side effects of pharmaceutical sleep medications.

Trends in the market: One of the key trends in the Sleep Aids market in Russia is the growing popularity of herbal and natural sleep aids. Customers are increasingly seeking out products that are made from natural ingredients and have minimal side effects. This trend is in line with the global shift towards natural and holistic health solutions. As a result, companies in the Sleep Aids market are introducing new products that cater to this demand, such as herbal teas, essential oils, and supplements containing natural sleep-promoting ingredients. Another trend in the Sleep Aids market in Russia is the increasing availability of sleep aids through e-commerce platforms. Online shopping has become increasingly popular in Russia, and customers are turning to online retailers to purchase sleep aids conveniently and discreetly. This trend is further supported by the wide range of options available online, allowing customers to compare products and read reviews before making a purchase.

Local special circumstances: Russia has a large population and a significant portion of the population suffers from sleep disorders. Factors such as stress, long working hours, and a fast-paced lifestyle contribute to the prevalence of sleep disorders in the country. This provides a significant market opportunity for sleep aid manufacturers to cater to the needs of the population.

Underlying macroeconomic factors: The growing Sleep Aids market in Russia can also be attributed to the overall growth of the healthcare industry in the country. The Russian government has been investing in healthcare infrastructure and initiatives to improve the overall health and well-being of its citizens. This has led to increased awareness and access to healthcare services, including sleep disorder diagnosis and treatment. As a result, more individuals are seeking out sleep aids to address their sleep issues, driving the growth of the Sleep Aids market. In conclusion, the Sleep Aids market in Russia is experiencing growth due to changing customer preferences, including a demand for natural and non-habit forming sleep aids, as well as the increasing availability of sleep aids through e-commerce platforms. The prevalence of sleep disorders in the country and the government's focus on improving healthcare services also contribute to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.